A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2017
At a glance
- Drugs NA 1 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms FRONTIER
- Sponsors NoNO
- 04 May 2016 Planned End Date changed from 1 Mar 2017 to 1 May 2019.
- 04 May 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2019.
- 19 Feb 2016 Trial design presented at the 41st International Stroke Conference